INCIDENCE OF MULTIPLE-MYELOMA IN OLMSTED COUNTY, MINNESOTA - 1978 THROUGH 1990, WITH A REVIEW OF THE TREND SINCE 1945

被引:44
作者
KYLE, RA [1 ]
BEARD, CM [1 ]
OFALLON, WM [1 ]
KURLAND, LT [1 ]
机构
[1] MAYO CLIN & MAYO FDN, DEPT HLTH SCI RES, ROCHESTER, MN 55905 USA
关键词
D O I
10.1200/JCO.1994.12.8.1577
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Incidence rates of multiple myeloma appear to have increased in recent decades, but it is difficult to compare the incidence rates over time because of changes in laboratory procedures, differences in diagnostic criteria, and variations in indexing of medical records. However, Olmsted County, Minnesota, provides a rare opportunity to minimize these limitations, because the medical care has been provided mainly by the Mayo Clinic. Patients and Methods: Records of Olmsted County residents with a diagnosis of multiple myeloma from January 1, 1978 through December 31, 1990 were reviewed. Criteria for diagnosis and residency were the same as in previous Olmsted County studies. Results: The incidence rate per 100,000 age-adjusted to the 1950 United States white population was 5.4 for males and 2.8 for females; the overall rate was 4.1. The rates were age-adjusted to the 1950 United States population for comparison with earlier data from this population. The rates increased with age for both sexes. There was no significant change in incidence rates from 1945 through 1990. A comparison of the median age for Olmsted County patients with the age of those referred to the Mayo Clinic from elsewhere indicated that the local patients were appreciably older (74 v. 62 years, respectively). Thirty-two of 55 patients (58%) with multiple myeloma from 1978 through 1990 had a monoclonal plasma- cell proliferative process before the diagnosis of multiple myeloma. Conclusion: The incidence rate of multiple myeloma in Olmsted County, Minnesota, has not changed significantly during the past 46 years. We believe that reports of increasing rates over time are mainly due to improved case ascertainment.
引用
收藏
页码:1577 / 1583
页数:7
相关论文
共 31 条
[1]  
BERGSTALH EJ, 1992, CALCULATING INCIDENC
[2]  
BERGSTRALH EJ, 1988, TECHNICAL REPORT SER, V38
[3]   MULTIPLE-MYELOMA - EPIDEMIOLOGICAL FEATURES IN A WELL-DEFINED POPULATION IN BURGUNDY, FRANCE [J].
CARLI, PM ;
BAILLY, F ;
TAVERNIER, C ;
MILAN, C ;
HEUDES, D ;
LAVAULT, JF .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1989, 18 (02) :330-333
[4]   INTERNATIONAL TIME TRENDS FOR MULTIPLE-MYELOMA [J].
CUZICK, J .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 609 :205-214
[5]   IS BRAIN CANCER MORTALITY INCREASING IN INDUSTRIAL-COUNTRIES [J].
DAVIS, DL ;
AHLBOM, A ;
HOEL, D ;
PERCY, C .
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 1991, 19 (04) :421-431
[6]  
DAVIS DL, 1990, ANN NY ACAD SCI, V609, P5
[7]   INTERNATIONAL TRENDS IN CANCER MORTALITY IN FRANCE, WEST-GERMANY, ITALY, JAPAN, ENGLAND AND WALES, AND THE USA [J].
DAVIS, DL ;
HOEL, D ;
FOX, J ;
LOPEZ, A .
LANCET, 1990, 336 (8713) :474-481
[8]  
GREENWALD P, 1976, CANCER INCIDENCE MOR
[9]  
HANSEN NE, 1989, EUR J HAEMATOL, V42, P72
[10]   IMPACT OF ACTIVE AND PASSIVE EXCLUSIONS ON THE RESULTS OF A CLINICAL-TRIAL IN MULTIPLE-MYELOMA [J].
HJORTH, M ;
HOLMBERG, E ;
RODJER, S ;
WESTIN, J ;
FAGERBERG, B ;
MAGNUSSON, B ;
WESTIN, J ;
RODJER, S ;
WILLSTRAND, M ;
MAGNUS, C ;
LENNARTSSON, J ;
SVENSSON, R ;
HELLQVIST, L ;
LANGER, L ;
HJORTH, M ;
HOFFMAN, P ;
LARSSON, S ;
OLSSON, S ;
RINDNER, A ;
EVALDSSON, U ;
OLSSON, K ;
GRANDE, B ;
LINDQVIST, O ;
BLOM, HL ;
SARG, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 80 (01) :55-61